Introduction Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases
worldwide. As the pandemic has progressed, the understanding of this disease has evolved …

In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection
itself, an increase in the incidence of antimicrobial resistance poses collateral damage to the …

The clinical course and outcome of COVID-19 are highly variable, ranging from
asymptomatic infections to severe disease and death. Understanding the risk factors of …

Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal
infections. Most documented cases have been reported in patients with diabetes mellitus …

Background Patients with severe COVID-19 have emerged as a population at high risk of
invasive fungal infections (IFIs). However, to our knowledge, the prevalence of IFIs has not …

The novel coronavirus infectious disease-2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has traumatized the whole world with the …

The innate immune system initiates cell death pathways in response to pathogens and
cellular stress. Cell death can be either non-lytic (apoptosis) or lytic (PANoptosis, pyroptosis …

Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is threatening public health. A large number of …

Background: Microbial drug resistance is one of the biggest public health problems.
Antibiotic consumption is an essential factor for the emergence and spread of multiresistant …

Purpose To investigate the prevalence, incidence and characteristics of bacterial infections
and their impact on outcome in critically ill patients infected with COVID-19. Methods We …